Lumexa Imaging entered into an amended Credit Agreement providing a secured term loan of about $823 million and a $250 million secured revolving credit facility to refinance debt and bolster liquidity. The facilities bear interest at SOFR plus 2.50% or the Prime Rate plus 1.50%, with the revolver maturing in December 2030 and the term loan in December 2032. The agreement includes customary covenants and a financial test if revolver usage exceeds 40%, requiring a maximum 7.50x consolidated net leverage ratio.
Agreement details:
- Agreement type: Secured term loan and revolving credit facility under amended credit agreement
- Counterparty: Barclays Bank, as administrative agent, and other lenders
- Signed / Effective: Jun 30 2026 / same
- Duration / Termination: Revolver: to Dec 2030; Term Loan: to Dec 2032
- Reason: Refinance debt and enhance liquidity
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.